Sign inJoin waitlistJoin the waitlist

Kevin Blinder

Physician · Retina Consultants of America

Credentials: · · · ·

History

Retina Consultants of America
Present

Louisiana State University SOM-New Orleans-Retina and Vitreous Surgery
1989–1990
Ophthalmology
University of Missouri School of Medicine
1986–1989
Preliminary or Transitional Year
1985–1986
Univ of Missouri, Kansas City Sch of Med
1981–1985

Research

Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3
Ophthalmology · 2003 · First of 22 authors · 301 citations
Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary…
JAMA Ophthalmology · 2018 · 289 citations
A technique for retinal pigment epithelium transplantation for age-related macular degeneration secondary to extensive subfoveal scarring
Case report · Ophthalmic surgery · 1991 · 185 citations

Gaurav Shah
50 papers
Gholam Peyman
15 papers
CP
Christopher Paris
14 papers
DJ
Daniel Joseph
9 papers
MG
Mark Grand
9 papers
NH
Nancy Holekamp
9 papers
Uday Desai
9 papers · 8 as a fellow
Asheesh Tewari
7 papers · 3 as a fellow
RM
Robert Mittra
7 papers
AA
Arghavan Almony
6 papers · 1 as a resident
Dean Eliott
6 papers
ER
Edwin Ryan
6 papers

Clinical trials

Intravitreal Aflibercept Injection (IAI) for Presumed Ocular Histoplasmosis Syndrome
Principal investigator · Completed · Phase 1
Retina Research Institute, LLC
2012–2015
Ranibizumab Versus PDT for Presumed Ocular Histoplasmosis
Principal investigator · Unknown · Phase 2
Barnes Retina Institute
2007–2010